EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes

Taro Kishi, Leslie Citrome, Kenji Sakuma, Shun Hamanaka, Yasufumi Nishii, Masakazu Hatano, Osamu Furukawa, Youichi Saito, Nakao Iwata

Pharmacopsychiatry · 2025-11 · 58 (06) · 249-254

DOI: 10.1055/a-2506-7022 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pharmacopsychiatry, online erschienen am 29.01.2025. Verfasst von Taro Kishi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. Hauptthemen laut MEDLINE: Schizophrenia, Psychotic Disorders, Antipsychotic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The United States Food and Drug Administration approved the xanomeline-trospium combination in September 2024 for treating schizophrenia, based in part on three double-blind, randomized placebo-controlled trials in adults with schizophrenia experiencing acute psychosis. This random-effects model pairwise meta-analysis of those three trials found that xanomeline-trospium was comparable to placebo in terms of all-cause discontinuation, discontinuation rate due to adverse events, Simpson–Angus Scale score change, Barnes Akathisia Rating Scale score change, body weight change, body mass index change, blood pressure change, serum total cholesterol change, blood glucose change, QTc interval changes, and the incidence of headache, somnolence, insomnia, dizziness, akathisia, agitation, tachycardia, gastroesophageal reflux disease, diarrhea, increased weight, and decreased appetite. However, xanomeline-trospium was associated with a higher incidence of at least one adverse event, dry mouth, hypertension, nausea, vomiting, dyspepsia, and constipation, and increased serum triglyceride compared with placebo. Notably, xanomeline-trospium demonstrated superior efficacy than placebo in improving the Positive and Negative Syndrome Scale (PANSS) total score, PANSS positive subscale score, and PANSS negative subscale score.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaPsychotic DisordersAntipsychotic AgentsHumansAdultRandomized Controlled Trials as TopicTreatment Outcome

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA.
  • Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Department of Psychiatry, Okehazama Hospital, Toyoake, Aichi, Japan.
  • Department of Psychiatry, Nansei Hospital, Matsusaka, Mie, Japan.

Zitieren

APA

Kishi, T., Citrome, L., Sakuma, K., Hamanaka, S., Nishii, Y., Hatano, M., Furukawa, O., Saito, Y., & Iwata, N. (2025). Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes. Pharmacopsychiatry, 58(06), 249-254. https://doi.org/10.1055/a-2506-7022

Vancouver

Kishi T, Citrome L, Sakuma K, Hamanaka S, Nishii Y, Hatano M, et al. Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes. Pharmacopsychiatry. 2025;58(06):249-254. doi:10.1055/a-2506-7022

BibTeX
@article{Kishi2025,
  author = {Kishi, Taro and Citrome, Leslie and Sakuma, Kenji and Hamanaka, Shun and Nishii, Yasufumi and Hatano, Masakazu and Furukawa, Osamu and Saito, Youichi and Iwata, Nakao},
  title = {Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes},
  journal = {Pharmacopsychiatry},
  year = {2025},
  volume = {58},
  number = {06},
  pages = {249--254},
  doi = {10.1055/a-2506-7022}
}
Kostenlos starten →